Meeting of the CDC/HRSA Advisory Committee on HIV, Viral Hepatitis and STD Prevention and Treatment, 47180 [2018-20269]

Download as PDF 47180 Federal Register / Vol. 83, No. 181 / Tuesday, September 18, 2018 / Notices the committee. Oral presentations from the public will be scheduled between approximately 8:30 a.m. and 10:30 a.m. on October 25, 2018. Those individuals interested in making formal oral presentations should notify the contact person and submit a brief statement of the general nature of the evidence or arguments they wish to present, the names and addresses of proposed participants, and an indication of the approximate time requested to make their presentation on or before October 1, 2018. Time allotted for each presentation may be limited. If the number of registrants requesting to speak is greater than can be reasonably accommodated during the scheduled open public hearing session, FDA may conduct a lottery to determine the speakers for the scheduled open public hearing session. The contact person will notify interested persons regarding their request to speak by October 2, 2018. Persons attending FDA’s advisory committee meetings are advised that FDA is not responsible for providing access to electrical outlets. For press inquiries, please contact the Office of Media Affairs at fdaoma@ fda.hhs.gov or 301–796–4540. FDA welcomes the attendance of the public at its advisory committee meetings and will make every effort to accommodate persons with disabilities. If you require accommodations due to a disability, please contact LaToya Bonner (see FOR FURTHER INFORMATION CONTACT) at least 7 days in advance of the meeting. FDA is committed to the orderly conduct of its advisory committee meetings. Please visit our website at https://www.fda.gov/ AdvisoryCommittees/ AboutAdvisoryCommittees/ ucm111462.htm for procedures on public conduct during advisory committee meetings. Notice of this meeting is given under the Federal Advisory Committee Act (5 U.S.C. app. 2). Dated: September 13, 2018. Leslie Kux, Associate Commissioner for Policy. daltland on DSKBBV9HB2PROD with NOTICES [FR Doc. 2018–20233 Filed 9–17–18; 8:45 am] BILLING CODE 4164–01–P VerDate Sep<11>2014 19:14 Sep 17, 2018 Jkt 244001 DEPARTMENT OF HEALTH AND HUMAN SERVICES Health Resources and Services Administration Meeting of the CDC/HRSA Advisory Committee on HIV, Viral Hepatitis and STD Prevention and Treatment Health Resources and Services Administration (HRSA), Department of Health and Human Services (HHS). ACTION: Notice. AGENCY: The Centers for Disease Control and Prevention (CDC)/HRSA Advisory Committee on HIV, Viral Hepatitis and STD Prevention and Treatment (CHACHSPT) has scheduled a public meeting. Information about the CHACHSPT can be found here: https:// www.cdc.gov/maso/facm/ facmchachspt.html. An agenda may be requested by emailing CHACAdvisoryComm@hrsa.gov. DATES: November 7, 2018, 8:30 a.m.– 5:00 p.m. ET and November 8, 2018, 8:30 a.m.–3:30 p.m. ET. ADDRESSES: This meeting will be held in-person and by webinar and teleconference. The address for the meeting is DoubleTree by Hilton, Bethesda, 8120 Wisconsin Avenue, Bethesda, Maryland 20814. • Adobe Connect URL link: https:// hrsa.connectsolutions.com/chac_ meeting/. • Conference call-in number: 888– 324–9617, Passcode 9245865. FOR FURTHER INFORMATION CONTACT: Theresa Jumento, Chief, Policy Development Branch, HRSA, HIV/AIDS Bureau (HAB), Division of Policy and Data, 5600 Fishers Lane, Room 9N156, or by email at CHACAdvisoryComm@ hrsa.gov. SUMMARY: The CHACHSPT was established under Section 222 of the Public Health Service (PHS) Act, [42 U.S.C. Section 217a], as amended. The purpose of the CHACHSPT is to advise the Secretary of HHS, the Director of the CDC, and the Administrator of HRSA on the objectives, strategies, policies, and priorities for HIV, viral hepatitis, and other STD prevention and treatment efforts. This includes, but is not limited to, surveillance of HIV infection, viral hepatitis, and other STDs; responses to related emerging health needs; and epidemiologic, behavioral, health services, and laboratory research on HIV/AIDS, viral hepatitis, and other STDs. The CHACHSPT also provides advice regarding policy issues related to HIV/viral hepatitis/STD professional education, patient healthcare delivery, research and training, and prevention services. During the November 7–8, 2018, meeting, the CHACHSPT will discuss the following topics: • CHACHSPT workgroup reports and findings; • updates from CDC, HRSA, and HRSA HAB; • strategies for serving women, infants, children, and youth; • agencies’ responses to the opioid crisis; and • telemedicine initiatives. Agenda items are subject to change as priorities dictate. Refer to the CHACHSPT website for any updated information concerning the meeting. Members of the public will have the opportunity to provide comments. Public participants may submit written statements in advance of the scheduled meeting. Oral comments will be honored in the order they are requested and may be limited as time allows. Requests to submit a written statement or make oral comments to CHACHSPT should be sent by email to CHACAdvisoryComm@hrsa.gov or by mail to Theresa Jumento at the address above at least 3 business days prior to the meeting. Individuals who plan to attend and need special assistance or another reasonable accommodation should notify Theresa Jumento at the address listed above at least 10 business days prior to the meeting. Amy P. McNulty, Acting Director, Division of the Executive Secretariat. [FR Doc. 2018–20269 Filed 9–17–18; 8:45 am] BILLING CODE 4165–15–P SUPPLEMENTARY INFORMATION: PO 00000 Frm 00057 Fmt 4703 Sfmt 4703 DEPARTMENT OF HEALTH AND HUMAN SERVICES National Advisory Council on Migrant Health Health Resources and Services Administration (HRSA), Department of Health and Human Services (HHS). ACTION: Meeting notice. AGENCY: The Secretary’s National Advisory Council on Migrant Health (NACMH) has scheduled a public meeting. Information about NACMH and the agenda for this meeting can be found on the NACMH website at: https://bphc.hrsa.gov/quality improvement/strategicpartnerships/ nacmh/index.html. SUMMARY: E:\FR\FM\18SEN1.SGM 18SEN1

Agencies

[Federal Register Volume 83, Number 181 (Tuesday, September 18, 2018)]
[Notices]
[Page 47180]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-20269]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Health Resources and Services Administration


Meeting of the CDC/HRSA Advisory Committee on HIV, Viral 
Hepatitis and STD Prevention and Treatment

AGENCY: Health Resources and Services Administration (HRSA), Department 
of Health and Human Services (HHS).

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Centers for Disease Control and Prevention (CDC)/HRSA 
Advisory Committee on HIV, Viral Hepatitis and STD Prevention and 
Treatment (CHACHSPT) has scheduled a public meeting. Information about 
the CHACHSPT can be found here: https://www.cdc.gov/maso/facm/facmchachspt.html. An agenda may be requested by emailing 
[email protected].

DATES: November 7, 2018, 8:30 a.m.-5:00 p.m. ET and November 8, 2018, 
8:30 a.m.-3:30 p.m. ET.

ADDRESSES: This meeting will be held in-person and by webinar and 
teleconference. The address for the meeting is DoubleTree by Hilton, 
Bethesda, 8120 Wisconsin Avenue, Bethesda, Maryland 20814.
     Adobe Connect URL link: https://hrsa.connectsolutions.com/chac_meeting/.
     Conference call-in number: 888-324-9617, Passcode 9245865.

FOR FURTHER INFORMATION CONTACT: Theresa Jumento, Chief, Policy 
Development Branch, HRSA, HIV/AIDS Bureau (HAB), Division of Policy and 
Data, 5600 Fishers Lane, Room 9N156, or by email at 
[email protected].

SUPPLEMENTARY INFORMATION: The CHACHSPT was established under Section 
222 of the Public Health Service (PHS) Act, [42 U.S.C. Section 217a], 
as amended.
    The purpose of the CHACHSPT is to advise the Secretary of HHS, the 
Director of the CDC, and the Administrator of HRSA on the objectives, 
strategies, policies, and priorities for HIV, viral hepatitis, and 
other STD prevention and treatment efforts. This includes, but is not 
limited to, surveillance of HIV infection, viral hepatitis, and other 
STDs; responses to related emerging health needs; and epidemiologic, 
behavioral, health services, and laboratory research on HIV/AIDS, viral 
hepatitis, and other STDs. The CHACHSPT also provides advice regarding 
policy issues related to HIV/viral hepatitis/STD professional 
education, patient healthcare delivery, research and training, and 
prevention services.
    During the November 7-8, 2018, meeting, the CHACHSPT will discuss 
the following topics:
     CHACHSPT workgroup reports and findings;
     updates from CDC, HRSA, and HRSA HAB;
     strategies for serving women, infants, children, and 
youth;
     agencies' responses to the opioid crisis; and
     telemedicine initiatives.

Agenda items are subject to change as priorities dictate. Refer to the 
CHACHSPT website for any updated information concerning the meeting.
    Members of the public will have the opportunity to provide 
comments. Public participants may submit written statements in advance 
of the scheduled meeting. Oral comments will be honored in the order 
they are requested and may be limited as time allows. Requests to 
submit a written statement or make oral comments to CHACHSPT should be 
sent by email to [email protected] or by mail to Theresa 
Jumento at the address above at least 3 business days prior to the 
meeting.
    Individuals who plan to attend and need special assistance or 
another reasonable accommodation should notify Theresa Jumento at the 
address listed above at least 10 business days prior to the meeting.

Amy P. McNulty,
Acting Director, Division of the Executive Secretariat.
[FR Doc. 2018-20269 Filed 9-17-18; 8:45 am]
BILLING CODE 4165-15-P